The total return over the past 12 months is -27.96% vs. +16.94% for the S&P 500. So far it's up +147.12% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (27.96%) | (19.68%) | (45.49%) | (52.09%) | N/A | N/A |
| Total Return CAGR | (27.96%) | (19.68%) | (45.49%) | (52.09%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
TuHURA Biosciences, Inc. (HURA)
| Year | Start price | End price | HURA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.76 | $1.87 | +147.12% | +14.51% | +132.61% |
| 2025 | $4.09 | $0.76 | (81.50%) | +17.72% | (99.22%) |
| 2024 | $5.95 | $4.09 | (31.26%) | +24.89% | (56.15%) |
| 2023 | $6.89 | $5.95 | (13.64%) | +26.19% | (39.83%) |
| 2022 | $25.50 | $6.89 | (72.98%) | (18.17%) | (54.81%) |
| 2021 | $64.00 | $25.50 | (60.16%) | +28.74% | (88.90%) |
| 2020 | $34.50 | $64.00 | +85.51% | +18.37% | +67.14% |
| 2019 | $170.99 | $34.50 | (79.82%) | +31.22% | (111.04%) |
| 2018 | $544.98 | $170.99 | (68.62%) | (4.56%) | (64.06%) |
| 2017 | $1,594.45 | $544.98 | (65.82%) | +21.70% | (87.52%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
